Drug Database
Back to search

Netherlands· NL-69f91909462e

Ryzodeg 100 eenheden/ml oplossing voor injectie in voorgevulde pen

A insulin degludec und insulin aspart product containing insuline aspart + insuline degludec, registered in Netherlands by Novo Nordisk A.S.. The same ATC class is registered in 9 of our 19 countries.

ATC A10AD06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRyzodeg 100 eenheden/ml oplossing voo…ATCA10AD06REGISTER NO.NL-69f91909462ePACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about insuline aspart + insuline degludecAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin degludec und insulin aspart is registered in 9 of 19 countries.

Countries holding a registration under ATC A10AD06 (insulin degludec und insulin aspart), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search insulin degludec und insulin aspart products by name

Insulin degludec und insulin aspart · ATC A10AD06

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
INSULINE ASPART + INSULINE DEGLUDEC
Manufacturer
Novo Nordisk A.S.
Country
Netherlands (NL)
ATC code
A10AD06
ATC class
Insulin degludec und Insulin aspart
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/12/806

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Insulin degludec und insulin aspart in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin degludec und insulin aspart products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Ryzodeg Flexpen, Ryzodeg Flextouch
  • Norway · Ryzodeg Flexpen, Ryzodeg Flextouch

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af367c45-c3e3-42a8-a7f6-e09177e22c81
GET /v1/drugs/af367c45-c3e3-42a8-a7f6-e09177e22c81?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ryzodeg-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Insulin degludec and insulin aspart",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp110865",
  "excipients": [
    "FENOL",
    "GLYCEROL (E 422)",
    "METACRESOL",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE",
    "ZINKDIACETAAT 0-WATER (E 650)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "INSULINE ASPART",
    "INSULINE DEGLUDEC"
  ],
  "leaflet_url": null,
  "authorised_at": "2013/01/21",
  "procedure_number": "EMEA/H/C/002499",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/12/806",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about insulin degludec und insulin aspart.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console